DE69214747T2 - N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen - Google Patents

N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen

Info

Publication number
DE69214747T2
DE69214747T2 DE69214747T DE69214747T DE69214747T2 DE 69214747 T2 DE69214747 T2 DE 69214747T2 DE 69214747 T DE69214747 T DE 69214747T DE 69214747 T DE69214747 T DE 69214747T DE 69214747 T2 DE69214747 T2 DE 69214747T2
Authority
DE
Germany
Prior art keywords
isoquinolein
preparation
pharmaceutical compositions
compositions containing
cycloalkanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69214747T
Other languages
English (en)
Other versions
DE69214747D1 (de
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Nicole Villeneuve
Philip Janiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69214747D1 publication Critical patent/DE69214747D1/de
Application granted granted Critical
Publication of DE69214747T2 publication Critical patent/DE69214747T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69214747T 1991-07-31 1992-07-31 N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen Expired - Fee Related DE69214747T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109720A FR2679907B1 (fr) 1991-07-31 1991-07-31 Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
DE69214747D1 DE69214747D1 (de) 1996-11-28
DE69214747T2 true DE69214747T2 (de) 1997-05-07

Family

ID=9415765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214747T Expired - Fee Related DE69214747T2 (de) 1991-07-31 1992-07-31 N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen

Country Status (14)

Country Link
US (1) US5298503A (de)
EP (1) EP0527079B1 (de)
JP (1) JPH0720954B2 (de)
AT (1) ATE144510T1 (de)
AU (1) AU645917B2 (de)
CA (1) CA2074963A1 (de)
DE (1) DE69214747T2 (de)
DK (1) DK0527079T3 (de)
ES (1) ES2095431T3 (de)
FR (1) FR2679907B1 (de)
GR (1) GR3021769T3 (de)
IE (1) IE922524A1 (de)
NZ (1) NZ243784A (de)
ZA (1) ZA925782B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011939A1 (fr) * 1995-09-28 1997-04-03 Kaken Pharmaceutical Co., Ltd. Procede d'elaboration de 4-methylenepiperidines
WO1997046532A1 (en) * 1996-06-03 1997-12-11 Boehringer Ingelheim Pharmaceuticals, Inc. 2-benzyl-4-sulfonyl-4h-isoquinolin-1,3-diones and their use as anti-inflammatory agents
WO2007026664A1 (ja) * 2005-08-30 2007-03-08 Asahi Kasei Pharma Corporation スルホンアミド化合物
WO2008105058A1 (ja) * 2007-02-27 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド化合物
US7964613B2 (en) * 2007-02-28 2011-06-21 Asahi Kasei Pharma Corporation Sulfonamide compound
US8232292B2 (en) 2007-07-02 2012-07-31 Asahi Kasei Pharma Corporation Sulfonamide compound and crystal thereof
EP3257881B1 (de) 2015-02-13 2020-09-02 Unimatec Co., Ltd. Fluorhaltiges polymer und oberflächenmodifikator damit als wirkstoff

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583287D1 (de) * 1984-12-27 1991-07-25 Asahi Chemical Ind Substituierte isochinolinsulfonyl-verbindungen.
JPH0667926B2 (ja) * 1985-11-12 1994-08-31 旭化成工業株式会社 環状のイソキノリンスルホンアミド誘導体

Also Published As

Publication number Publication date
GR3021769T3 (en) 1997-02-28
ATE144510T1 (de) 1996-11-15
JPH0720954B2 (ja) 1995-03-08
AU645917B2 (en) 1994-01-27
FR2679907A1 (fr) 1993-02-05
EP0527079A1 (de) 1993-02-10
ZA925782B (en) 1993-03-02
FR2679907B1 (fr) 1995-01-20
NZ243784A (en) 1994-07-26
US5298503A (en) 1994-03-29
CA2074963A1 (fr) 1993-02-01
IE922524A1 (en) 1993-02-10
AU2067592A (en) 1993-02-04
DK0527079T3 (da) 1997-04-21
EP0527079B1 (de) 1996-10-23
DE69214747D1 (de) 1996-11-28
ES2095431T3 (es) 1997-02-16
JPH05208973A (ja) 1993-08-20

Similar Documents

Publication Publication Date Title
DE69131813D1 (de) Amido-3-Pyrazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE3851986D1 (de) Aminsäure-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE69202313D1 (de) Naphthylethylharnstoff und Naphthylethylthioharnstoff Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE69212007T2 (de) Phenylimidazolidine, Verfahren zu deren Herstellung, deren Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen
DE69215595D1 (de) Isochinolin-5-yl-Sulfonsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE69310602D1 (de) 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
ATE160344T1 (de) Heterozyklische alkylamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE66224T1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DE69406853T2 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE152707T1 (de) Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69214747D1 (de) N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69102477T2 (de) 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69201368T2 (de) 1-(Alkoxybenzyl)piperazineamide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69214113D1 (de) Neue Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE112275T1 (de) Disubstituierte polymethylenimine, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE105284T1 (de) Pyridazin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3667663D1 (de) Nitrosubstituierte heteroarylverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee